DII
BEAT

Domini Impact Investments’s BioTelemetry, Inc. BEAT Stock Holding History

Domini Impact Investments’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-3,952
Closed -$247K – 24
2019
Q1 		$247K Sell
3,952
-20
-0.5% -$1.37K 3.79% 12
2018
Q4 		$237K Buy
3,972
+102
+3% +$6.12K 4.78% 12
2018
Q3 		$249K Buy
+3,870
New +$216K 3.53% 15

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Domini Impact Investments's BEAT Position: Q2 2019 in Review

Domini Impact Investments sold out of BioTelemetry, Inc. (BEAT) in Q2 2019, closing a stake of 3,952 shares — an estimated $247K sold.

Domini Impact Investments first reported a position in BEAT in Q3 2018 and held it in 3 quarters. The position peaked at $249K in Q3 2018. 251 funds tracked by Wall St. Rank hold BEAT as of Q2 2019.

  • Domini Impact Investments reported no remaining BioTelemetry, Inc. position as of Q2 2019 after selling out during the quarter.
  • Domini Impact Investments sold 3,952 BioTelemetry, Inc. shares in Q2 2019, an estimated $247K.
  • Domini Impact Investments first reported a position in BioTelemetry, Inc. in Q3 2018 and held it in 3 quarters.
  • Domini Impact Investments's BioTelemetry, Inc. position peaked at $249K in Q3 2018.
  • 251 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q2 2019.

Based on Domini Impact Investments's 13F filing for Q2 2019, filed 13 Aug 2019.